New antibiotic OMN6 tested against tough lung infection
Disease control
Recruiting now
This phase 2a trial tests an experimental antibiotic called OMN6 in 54 adults with hospital-acquired or ventilator-associated pneumonia caused by Acinetobacter baumannii. Participants receive either OMN6 or a placebo, plus standard antibiotics, for one day. The main goal is to ch…
Phase: PHASE2 • Sponsor: Omnix Medical Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC